Nath Bio-Genes (India) Limited (NSE: NATHBIOGEN)

Nath Bio-Genes (India) Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 24, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Market Capitalization	3,549	3,308	2,684	4,055	5,705	2,571
Market Cap Growth	3.03%	23.22%	-33.79%	-28.93%	121.88%	-70.64%
Enterprise Value	4,803	4,283	3,836	4,810	6,296	3,037
Last Close Price	186.75	172.51	138.50	206.55	288.96	130.23
PE Ratio	9.05	8.35	7.67	-	10.25	5.09
PS Ratio	1.01	0.99	0.89	1.46	1.85	0.92
PB Ratio	0.61	0.54	0.47	0.75	0.93	0.46
P/TBV Ratio	0.65	0.55	0.48	0.77	0.95	0.47
P/FCF Ratio	-	6.92	7.56	-	-	49.06
P/OCF Ratio	36.31	4.43	7.00	23.78	512.62	27.13
EV/Sales Ratio	1.37	1.29	1.27	1.73	2.05	1.09
EV/EBITDA Ratio	9.69	8.57	7.85	12.77	9.38	5.54
EV/EBIT Ratio	10.40	9.16	8.36	13.91	9.79	5.69
EV/FCF Ratio	-26.30	8.96	10.81	-	-	57.94
Debt / Equity Ratio	0.20	0.18	0.18	0.17	0.16	0.13
Debt / EBITDA Ratio	2.57	2.21	2.15	2.47	1.50	1.28
Debt / FCF Ratio	-	2.31	2.96	-	-	13.38
Asset Turnover	0.42	0.40	0.39	0.36	0.40	0.41
Inventory Turnover	0.56	0.38	0.38	0.42	0.46	0.53
Quick Ratio	0.85	0.68	0.65	0.50	0.84	0.77
Current Ratio	2.84	2.18	2.40	2.41	3.10	2.78
Return on Equity (ROE)	6.33%	6.70%	6.28%	-11.67%	9.51%	9.48%
Return on Assets (ROA)	3.45%	3.49%	3.74%	2.83%	5.29%	4.85%
Return on Capital (ROIC)	3.89%	4.18%	4.37%	3.20%	5.99%	5.59%
Earnings Yield	11.05%	11.98%	13.04%	-16.62%	9.76%	19.63%
FCF Yield	-5.15%	14.46%	13.22%	-0.98%	-1.83%	2.04%
Dividend Yield	1.08%	1.16%	1.44%	0.97%	0.69%	-
Payout Ratio	9.86%	9.59%	10.86%	-	-	-
Buyback Yield / Dilution	0.20%	-	-	-	-	-
Total Shareholder Return	1.28%	1.16%	1.44%	0.97%	0.69%	-

Source: S&P Capital IQ. Standard template. Financial Sources.